Home
About
FAQ
History (38)
Does symptom onset to primary stroke center time goals affect stroke outcome?
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group.
Genetically diverse mice are novel and valuable models of age-associated susceptibility to Mycobacterium tuberculosis.
Epigenetic Modulation of Opioid Receptors by Drugs of Abuse.
Association of Atrial Fibrillation With Stroke and Dementia Accounting for Left Atrial Function and Size.
See All 38 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (82)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Scott D. Rhodes PhD
Wake Forest School of Medicine
Why?
Avinash K. Shetty MBBS, DCH, MD
Wake Forest School of Medicine
Why?
Kathryn E. Lancaster PhD, MPH
Wake Forest School of Medicine
Why?
Tiarney D. Ritchwood
Wake Forest School of Medicine
Why?
Caryn G. Morse MD, MPH
Wake Forest School of Medicine
Why?
Dustin M. Long
Wake Forest School of Medicine
Why?
Aimee M. Wilkin MD, MPH
Wake Forest School of Medicine
Why?
Ucheoma C. Nwaozuru PhD
Wake Forest School of Medicine
Why?
Katherine R. Schafer MD, FACP
Wake Forest School of Medicine
Why?
Kevin P. High MD
Wake Forest School of Medicine
Why?
Mark J. Ferris PhD
Wake Forest School of Medicine
Why?
Ryan C. Maves MD
Wake Forest School of Medicine
Why?
Elsayed Z. Soliman MD, MS
Wake Forest School of Medicine
Why?
Beth A. Reboussin PhD
Wake Forest School of Medicine
Why?
Colin E. Bishop PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 6
Next
Prev
Search Criteria
HIV
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions